Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT05941637
What this trial is testing

An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)

Who this might be right for
Clear Cell Kidney CancerKidney CancerKidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations
Lynkcell Europe
Not applicableStudy completedNCT00898365
What this trial is testing

Study of Kidney Tumors in Younger Patients

Who this might be right for
Adult Cystic NephromaAnaplastic Kidney Wilms TumorAngiolipoma+22 more
Children's Oncology Group 8,000
Very early researchNot Yet RecruitingNCT07113977
What this trial is testing

Clinical Study of a Novel Humanized CD70-Targeted CAR-T Cell Incorporating TLR2 for Advanced Renal Cell Carcinoma Therapy

Who this might be right for
Advanced Renal Cell Carcinoma
Wei Guan 30
Early research (Phase 1)Looking for participantsNCT05856981
What this trial is testing

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultMetastatic Solid TumorRefractory Cancer+4 more
Sairopa B.V. 130
Not applicableLooking for participantsNCT05023265
What this trial is testing

Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT

Who this might be right for
Renal Cell Carcinoma
Sunnybrook Health Sciences Centre 70
Not applicableUnknownNCT04244136
What this trial is testing

Residual Normal Renal Parenchymal and Tumor Volume in Tumor Surgeries

Who this might be right for
Renal Cell Carcinoma
Assiut University 32
Testing effectiveness (Phase 2)Ended earlyNCT00089102
What this trial is testing

Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Medical University of South Carolina 9
Not applicableLooking for participantsNCT06536439
What this trial is testing

Planning Operative Strategy Using a Digital Renal Artery Clamping Tool

Who this might be right for
Kidney CancerKidney NeoplasmsKidney Diseases+3 more
University Hospital, Ghent 235
Not applicableEnded earlyNCT02005614
What this trial is testing

A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection

Who this might be right for
MelanomaRenal Cell CarcinomaSarcoma+5 more
Yale University 39
Large-scale testing (Phase 3)Study completedNCT02627963
What this trial is testing

Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
Carcinoma, Renal Cell
AVEO Pharmaceuticals, Inc. 350
Large-scale testing (Phase 3)Study completedNCT00606866
What this trial is testing

MRI Study of BAY 43-9006 in Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
University of Chicago 57
Testing effectiveness (Phase 2)Study completedNCT02060370
What this trial is testing

Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)

Who this might be right for
Genitourinary CancerKidney Cancer
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00003584
What this trial is testing

Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of New Mexico 35
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Not applicableLooking for participantsNCT05548621
What this trial is testing

A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)

Who this might be right for
Renal Cell CarcinomaRenal Cell Carcinoma Metastatic
St. Antonius Hospital 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07077083
What this trial is testing

CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)ccRCC
Massachusetts General Hospital 10
Early research (Phase 1)Active Not RecruitingNCT05783622
What this trial is testing

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+4 more
Janux Therapeutics 130
Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Not applicableNo Longer AvailableNCT03874455
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Who this might be right for
Epithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more
Epizyme, Inc.
Early research (Phase 1)Ended earlyNCT04429321
What this trial is testing

Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary

Who this might be right for
Renal Cell CarcinomaRenal Cell Carcinoma Stage IV
Abramson Cancer Center at Penn Medicine 1
Next Page